PNT
POINT Biopharma Global Inc. Common Stock
Delisted
PNT was delisted on the 26th of December, 2023.
109 hedge funds and large institutions have $446M invested in POINT Biopharma Global Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 20 funds opening new positions, 48 increasing their positions, 27 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
5% less capital invested
Capital invested by funds: $470M → $446M (-$24.8M)
Holders
109
Holding in Top 10
3
Calls
–
Puts
–
Top Buyers
| 1 | +$26.2M | |
| 2 | +$13.3M | |
| 3 | +$9.31M | |
| 4 |
OCAM
Onex Canada Asset Management
Toronto,
Ontario, Canada
|
+$5.56M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.77M |
Top Sellers
| 1 | -$21.9M | |
| 2 | -$10.2M | |
| 3 | -$7.73M | |
| 4 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$7.43M |
| 5 |
BlackRock
New York
|
-$5.53M |